| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Goblet Cells | 69 | 2024 | 299 | 20.540 |
Why?
|
| Conjunctiva | 72 | 2024 | 479 | 16.690 |
Why?
|
| Lacrimal Apparatus | 74 | 2023 | 223 | 12.190 |
Why?
|
| Mucins | 29 | 2023 | 568 | 8.110 |
Why?
|
| Dry Eye Syndromes | 41 | 2023 | 385 | 6.200 |
Why?
|
| Tears | 47 | 2023 | 251 | 4.700 |
Why?
|
| Calcium | 58 | 2024 | 5721 | 4.630 |
Why?
|
| Docosahexaenoic Acids | 13 | 2024 | 905 | 4.300 |
Why?
|
| Cholinergic Agonists | 19 | 2018 | 75 | 3.490 |
Why?
|
| Epidermal Growth Factor | 19 | 2013 | 695 | 3.070 |
Why?
|
| Carbachol | 29 | 2022 | 223 | 2.930 |
Why?
|
| Rats, Sprague-Dawley | 66 | 2024 | 8144 | 2.900 |
Why?
|
| Histamine | 8 | 2023 | 497 | 2.780 |
Why?
|
| Protein Kinase C | 32 | 2020 | 1199 | 2.610 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 14 | 2018 | 477 | 2.500 |
Why?
|
| Rats | 95 | 2024 | 23681 | 2.450 |
Why?
|
| Lipoxins | 5 | 2024 | 418 | 2.440 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 13 | 2018 | 473 | 2.280 |
Why?
|
| Conjunctivitis, Allergic | 7 | 2018 | 123 | 2.220 |
Why?
|
| Eicosapentaenoic Acid | 5 | 2020 | 560 | 1.890 |
Why?
|
| Meibomian Glands | 17 | 2023 | 73 | 1.880 |
Why?
|
| Thrombospondin 1 | 7 | 2023 | 257 | 1.830 |
Why?
|
| Mucin 5AC | 10 | 2020 | 97 | 1.730 |
Why?
|
| Sjogren's Syndrome | 8 | 2023 | 235 | 1.720 |
Why?
|
| Fura-2 | 15 | 2022 | 107 | 1.680 |
Why?
|
| Cells, Cultured | 49 | 2024 | 18942 | 1.660 |
Why?
|
| Annexin A1 | 2 | 2023 | 21 | 1.650 |
Why?
|
| Epithelial Cells | 22 | 2023 | 3665 | 1.560 |
Why?
|
| Receptors, Purinergic P2X7 | 6 | 2023 | 86 | 1.510 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2011 | 1245 | 1.500 |
Why?
|
| Adrenergic alpha-Agonists | 10 | 2007 | 177 | 1.450 |
Why?
|
| Keratomileusis, Laser In Situ | 5 | 2016 | 84 | 1.400 |
Why?
|
| Eyelid Diseases | 7 | 2023 | 157 | 1.370 |
Why?
|
| Blotting, Western | 32 | 2021 | 5031 | 1.330 |
Why?
|
| Cornea | 12 | 2019 | 1326 | 1.280 |
Why?
|
| MAP Kinase Signaling System | 9 | 2018 | 1477 | 1.270 |
Why?
|
| Protein Kinase C-alpha | 9 | 2013 | 113 | 1.230 |
Why?
|
| Photorefractive Keratectomy | 4 | 2016 | 38 | 1.210 |
Why?
|
| Adenosine Triphosphate | 7 | 2024 | 1986 | 1.190 |
Why?
|
| Eye Proteins | 15 | 2018 | 633 | 1.170 |
Why?
|
| Calcium Signaling | 10 | 2024 | 732 | 1.150 |
Why?
|
| Receptors, Histamine | 3 | 2018 | 23 | 1.150 |
Why?
|
| Cyclic AMP | 11 | 2019 | 1455 | 1.150 |
Why?
|
| Inflammasomes | 4 | 2023 | 527 | 1.120 |
Why?
|
| Conjunctival Diseases | 3 | 2022 | 110 | 1.090 |
Why?
|
| Animals | 144 | 2024 | 167777 | 1.090 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 5 | 2011 | 43 | 1.090 |
Why?
|
| Eye Diseases | 4 | 2020 | 651 | 1.070 |
Why?
|
| Glycoconjugates | 5 | 2018 | 88 | 1.020 |
Why?
|
| Type C Phospholipases | 7 | 2024 | 287 | 1.010 |
Why?
|
| Signal Transduction | 31 | 2022 | 23341 | 0.970 |
Why?
|
| Cell Proliferation | 21 | 2019 | 10417 | 0.950 |
Why?
|
| Receptors, Purinergic | 2 | 2016 | 66 | 0.920 |
Why?
|
| Vasoactive Intestinal Peptide | 19 | 2013 | 180 | 0.880 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 182 | 0.870 |
Why?
|
| Enzyme Activation | 22 | 2013 | 3593 | 0.810 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 15 | 2011 | 426 | 0.810 |
Why?
|
| Isoenzymes | 14 | 2008 | 1686 | 0.800 |
Why?
|
| Receptors, Adrenergic | 3 | 2016 | 155 | 0.790 |
Why?
|
| Phospholipase D | 4 | 2018 | 67 | 0.780 |
Why?
|
| Phenylephrine | 13 | 2011 | 293 | 0.770 |
Why?
|
| Receptors, Cholinergic | 4 | 2016 | 241 | 0.740 |
Why?
|
| Protein Kinases | 4 | 2021 | 1610 | 0.710 |
Why?
|
| Conjunctivitis | 1 | 2021 | 155 | 0.690 |
Why?
|
| Phospholipases A2 | 4 | 2022 | 197 | 0.680 |
Why?
|
| Receptors, Muscarinic | 6 | 2007 | 157 | 0.670 |
Why?
|
| Muscle Cells | 1 | 2020 | 194 | 0.670 |
Why?
|
| Receptors, Lipoxin | 2 | 2017 | 83 | 0.660 |
Why?
|
| Inflammation | 7 | 2024 | 10719 | 0.660 |
Why?
|
| Ocular Physiological Phenomena | 2 | 2019 | 67 | 0.660 |
Why?
|
| Xerostomia | 2 | 2017 | 94 | 0.650 |
Why?
|
| Leukotriene B4 | 1 | 2020 | 280 | 0.650 |
Why?
|
| Lasers, Excimer | 3 | 2016 | 69 | 0.640 |
Why?
|
| Male | 122 | 2024 | 358742 | 0.590 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 1753 | 0.590 |
Why?
|
| Neurotransmitter Agents | 7 | 2018 | 663 | 0.580 |
Why?
|
| Nanofibers | 1 | 2016 | 66 | 0.540 |
Why?
|
| Parasympathetic Nervous System | 6 | 2013 | 141 | 0.540 |
Why?
|
| Extracellular Matrix | 3 | 2021 | 1723 | 0.540 |
Why?
|
| Histamine Agonists | 2 | 2012 | 13 | 0.530 |
Why?
|
| Epithelium, Corneal | 6 | 2019 | 249 | 0.520 |
Why?
|
| Microscopy, Fluorescence | 12 | 2014 | 2646 | 0.500 |
Why?
|
| Peroxidases | 6 | 2007 | 134 | 0.500 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 6 | 2022 | 483 | 0.480 |
Why?
|
| Enzyme Inhibitors | 18 | 2013 | 3709 | 0.480 |
Why?
|
| Alanine | 2 | 2008 | 603 | 0.470 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 3 | 1999 | 9 | 0.470 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2018 | 10747 | 0.470 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2007 | 198 | 0.470 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 475 | 0.460 |
Why?
|
| Organ Culture Techniques | 5 | 2018 | 795 | 0.460 |
Why?
|
| Phosphorylation | 18 | 2018 | 8297 | 0.460 |
Why?
|
| Stem Cells | 7 | 2023 | 3521 | 0.460 |
Why?
|
| Nerve Regeneration | 2 | 2018 | 791 | 0.460 |
Why?
|
| Hypersensitivity | 2 | 2024 | 1155 | 0.450 |
Why?
|
| Ophthalmic Solutions | 7 | 2024 | 304 | 0.450 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2013 | 5 | 0.440 |
Why?
|
| Bodily Secretions | 3 | 2021 | 27 | 0.440 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2013 | 7 | 0.440 |
Why?
|
| Tetradecanoylphorbol Acetate | 10 | 2011 | 818 | 0.440 |
Why?
|
| Quinolones | 2 | 2008 | 377 | 0.440 |
Why?
|
| Cytokines | 7 | 2018 | 7338 | 0.440 |
Why?
|
| Osmolar Concentration | 13 | 2020 | 660 | 0.440 |
Why?
|
| Neurons, Afferent | 4 | 2009 | 498 | 0.440 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 145 | 0.430 |
Why?
|
| Protein Kinase C-epsilon | 5 | 2008 | 43 | 0.430 |
Why?
|
| Sympathetic Nervous System | 5 | 2001 | 518 | 0.430 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2013 | 72 | 0.420 |
Why?
|
| Limbus Corneae | 4 | 2019 | 144 | 0.420 |
Why?
|
| Histamine H1 Antagonists | 1 | 2013 | 100 | 0.420 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 18125 | 0.410 |
Why?
|
| Cell Culture Techniques | 6 | 2019 | 1664 | 0.410 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2012 | 4567 | 0.410 |
Why?
|
| Nerve Growth Factors | 2 | 2007 | 562 | 0.410 |
Why?
|
| Lipocalin 1 | 1 | 2011 | 2 | 0.390 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2011 | 9 | 0.390 |
Why?
|
| Cell Count | 9 | 2018 | 1835 | 0.390 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2011 | 34 | 0.380 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 3 | 2011 | 18 | 0.380 |
Why?
|
| Cell Separation | 5 | 2006 | 1720 | 0.380 |
Why?
|
| Leukotriene D4 | 1 | 2011 | 33 | 0.380 |
Why?
|
| Leukotriene E4 | 1 | 2011 | 75 | 0.370 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 1460 | 0.370 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1826 | 0.370 |
Why?
|
| raf Kinases | 1 | 2011 | 118 | 0.360 |
Why?
|
| Neurons, Efferent | 2 | 2009 | 81 | 0.350 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.350 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2021 | 174 | 0.340 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 441 | 0.340 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 926 | 0.340 |
Why?
|
| Epithelium | 8 | 2023 | 1605 | 0.340 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2018 | 3801 | 0.340 |
Why?
|
| Cell Survival | 9 | 2024 | 5781 | 0.340 |
Why?
|
| Polymers | 1 | 2016 | 1615 | 0.330 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 280 | 0.330 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 373 | 0.330 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 256 | 0.320 |
Why?
|
| Peroxidase | 8 | 2011 | 605 | 0.320 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 855 | 0.320 |
Why?
|
| Caspase 1 | 2 | 2023 | 226 | 0.310 |
Why?
|
| Humans | 96 | 2024 | 758381 | 0.310 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 614 | 0.310 |
Why?
|
| Aniridia | 2 | 2018 | 36 | 0.300 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 150 | 0.300 |
Why?
|
| Lectins | 5 | 2022 | 484 | 0.300 |
Why?
|
| Cyclic GMP | 3 | 2005 | 395 | 0.300 |
Why?
|
| Phorbol 12,13-Dibutyrate | 5 | 2000 | 41 | 0.300 |
Why?
|
| Purinergic P2X Receptor Antagonists | 3 | 2011 | 23 | 0.290 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2023 | 346 | 0.290 |
Why?
|
| Muscle, Smooth | 3 | 2021 | 924 | 0.290 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 830 | 0.290 |
Why?
|
| Genes, src | 1 | 2006 | 51 | 0.280 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3156 | 0.280 |
Why?
|
| Mice | 25 | 2023 | 81107 | 0.270 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1870 | 0.270 |
Why?
|
| Plant Lectins | 2 | 2012 | 103 | 0.270 |
Why?
|
| Preservation, Biological | 2 | 2016 | 26 | 0.260 |
Why?
|
| Rats, Wistar | 10 | 2000 | 1844 | 0.260 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 11894 | 0.260 |
Why?
|
| Mucus | 3 | 2002 | 342 | 0.250 |
Why?
|
| Anti-Ulcer Agents | 1 | 2006 | 112 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2018 | 2443 | 0.250 |
Why?
|
| Homeostasis | 3 | 2022 | 3302 | 0.250 |
Why?
|
| Cryopreservation | 3 | 2017 | 717 | 0.250 |
Why?
|
| Microscopy, Confocal | 5 | 2017 | 1969 | 0.240 |
Why?
|
| Purinergic Agonists | 1 | 2024 | 5 | 0.240 |
Why?
|
| Interleukin-1beta | 3 | 2023 | 996 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 12 | 2023 | 22006 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2023 | 1825 | 0.240 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 4 | 2019 | 73 | 0.240 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1406 | 0.230 |
Why?
|
| Mouth Mucosa | 2 | 2017 | 426 | 0.230 |
Why?
|
| Calmodulin | 6 | 2003 | 217 | 0.230 |
Why?
|
| Benzalkonium Compounds | 1 | 2023 | 21 | 0.230 |
Why?
|
| Povidone-Iodine | 1 | 2024 | 55 | 0.230 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2023 | 48 | 0.230 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2023 | 10 | 0.230 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2023 | 32 | 0.230 |
Why?
|
| Female | 44 | 2024 | 390316 | 0.230 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 2825 | 0.220 |
Why?
|
| Preservatives, Pharmaceutical | 2 | 2023 | 34 | 0.220 |
Why?
|
| Myopia | 2 | 2016 | 245 | 0.220 |
Why?
|
| Contact Lenses | 2 | 2016 | 138 | 0.220 |
Why?
|
| Inositol Phosphates | 3 | 1994 | 176 | 0.220 |
Why?
|
| Keratoconjunctivitis | 3 | 2014 | 40 | 0.220 |
Why?
|
| DNA | 2 | 2016 | 7199 | 0.210 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2023 | 146 | 0.210 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 43 | 0.210 |
Why?
|
| Phospholipases | 1 | 2022 | 76 | 0.210 |
Why?
|
| Chlorhexidine | 1 | 2024 | 160 | 0.210 |
Why?
|
| Blepharitis | 1 | 2022 | 35 | 0.210 |
Why?
|
| RNA, Messenger | 10 | 2013 | 12760 | 0.210 |
Why?
|
| Leukotrienes | 2 | 2022 | 231 | 0.210 |
Why?
|
| Immunohistochemistry | 8 | 2017 | 11070 | 0.200 |
Why?
|
| Histamine Antagonists | 2 | 2012 | 90 | 0.200 |
Why?
|
| Fluorescent Dyes | 3 | 2018 | 1897 | 0.200 |
Why?
|
| Dihydrotestosterone | 1 | 2022 | 195 | 0.200 |
Why?
|
| Receptor Cross-Talk | 2 | 2013 | 116 | 0.200 |
Why?
|
| Interleukin-18 | 1 | 2023 | 250 | 0.200 |
Why?
|
| Purinergic P2X Receptor Agonists | 2 | 2011 | 5 | 0.200 |
Why?
|
| Carrier Proteins | 3 | 2013 | 4937 | 0.190 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 168 | 0.190 |
Why?
|
| Estrone | 1 | 2022 | 232 | 0.190 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2024 | 247 | 0.190 |
Why?
|
| Focal Adhesion Kinase 2 | 3 | 2007 | 87 | 0.190 |
Why?
|
| Dinoprostone | 1 | 2024 | 598 | 0.190 |
Why?
|
| Keratins | 3 | 2012 | 497 | 0.190 |
Why?
|
| Keratinocytes | 2 | 2016 | 790 | 0.190 |
Why?
|
| Oxytocics | 1 | 2021 | 65 | 0.190 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 3 | 2007 | 100 | 0.190 |
Why?
|
| Body Fluids | 1 | 2002 | 319 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2012 | 2470 | 0.180 |
Why?
|
| Chronic Disease | 5 | 2018 | 9266 | 0.180 |
Why?
|
| Proteins | 7 | 2003 | 6026 | 0.170 |
Why?
|
| Intracellular Space | 1 | 2021 | 197 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 1171 | 0.170 |
Why?
|
| Temperature | 2 | 2017 | 2219 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2000 | 240 | 0.170 |
Why?
|
| Cyclic CMP | 2 | 2010 | 6 | 0.170 |
Why?
|
| Organ Preservation | 2 | 2014 | 379 | 0.170 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 3433 | 0.170 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2018 | 314 | 0.160 |
Why?
|
| Keratin-7 | 3 | 2011 | 55 | 0.160 |
Why?
|
| Hyperthermia, Induced | 1 | 2022 | 416 | 0.160 |
Why?
|
| Chemokine CXCL2 | 1 | 2018 | 108 | 0.160 |
Why?
|
| Submandibular Gland | 1 | 1998 | 87 | 0.160 |
Why?
|
| Tissue Culture Techniques | 2 | 2021 | 290 | 0.160 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 580 | 0.150 |
Why?
|
| Muscle Contraction | 3 | 2021 | 1196 | 0.150 |
Why?
|
| Antioxidants | 1 | 2006 | 1662 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2021 | 536 | 0.150 |
Why?
|
| Corneal Transplantation | 2 | 2019 | 321 | 0.150 |
Why?
|
| Prostaglandins | 2 | 2017 | 398 | 0.150 |
Why?
|
| Interleukin-5 | 1 | 2018 | 269 | 0.150 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2007 | 153 | 0.150 |
Why?
|
| Potassium Chloride | 1 | 2018 | 230 | 0.150 |
Why?
|
| Protective Agents | 1 | 2018 | 150 | 0.150 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 89 | 0.150 |
Why?
|
| Oxytocin | 1 | 2021 | 401 | 0.150 |
Why?
|
| Substance P | 1 | 2018 | 333 | 0.140 |
Why?
|
| Corneal Stroma | 1 | 2018 | 171 | 0.140 |
Why?
|
| Leukotriene A4 | 1 | 2017 | 24 | 0.140 |
Why?
|
| Guanylate Cyclase | 3 | 2005 | 205 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2020 | 787 | 0.140 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 91 | 0.140 |
Why?
|
| Ovalbumin | 1 | 2018 | 673 | 0.140 |
Why?
|
| Transportation | 1 | 2018 | 214 | 0.140 |
Why?
|
| Mouth | 2 | 2016 | 380 | 0.130 |
Why?
|
| Eyelids | 1 | 2018 | 277 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2131 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2018 | 240 | 0.130 |
Why?
|
| Amnion | 2 | 2015 | 197 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2018 | 312 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2018 | 372 | 0.130 |
Why?
|
| Staining and Labeling | 2 | 2018 | 1083 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 1078 | 0.130 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 2 | 2006 | 24 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2015 | 15638 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 604 | 0.130 |
Why?
|
| Rats, Inbred Strains | 8 | 1992 | 2090 | 0.130 |
Why?
|
| Peptides | 3 | 2023 | 4341 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2024 | 2621 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating) | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cell Division | 5 | 2004 | 4459 | 0.130 |
Why?
|
| Titanium | 1 | 2018 | 484 | 0.130 |
Why?
|
| Corneal Topography | 1 | 2015 | 68 | 0.130 |
Why?
|
| Corneal Diseases | 2 | 2018 | 536 | 0.130 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2015 | 283 | 0.130 |
Why?
|
| Astigmatism | 1 | 2015 | 68 | 0.130 |
Why?
|
| Stimulation, Chemical | 7 | 1996 | 306 | 0.130 |
Why?
|
| Estradiol | 1 | 2022 | 1933 | 0.120 |
Why?
|
| Piperazines | 3 | 2012 | 2511 | 0.120 |
Why?
|
| Actins | 3 | 2021 | 2049 | 0.120 |
Why?
|
| Parasympathomimetics | 1 | 1994 | 27 | 0.120 |
Why?
|
| Ki-67 Antigen | 2 | 2008 | 631 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2016 | 298 | 0.120 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 2011 | 174 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 899 | 0.120 |
Why?
|
| Carcinogens | 1 | 1997 | 451 | 0.120 |
Why?
|
| Purine Nucleosides | 1 | 2014 | 30 | 0.120 |
Why?
|
| Purine Nucleotides | 1 | 2014 | 27 | 0.120 |
Why?
|
| Receptor, erbB-3 | 2 | 2007 | 143 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2018 | 1130 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2022 | 2211 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 1996 | 404 | 0.120 |
Why?
|
| Ionomycin | 2 | 2006 | 109 | 0.120 |
Why?
|
| Middle Aged | 24 | 2024 | 219560 | 0.120 |
Why?
|
| Aged | 22 | 2021 | 168217 | 0.120 |
Why?
|
| Apoptosis | 6 | 2016 | 9468 | 0.110 |
Why?
|
| Cell Membrane | 6 | 2017 | 3680 | 0.110 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2013 | 21 | 0.110 |
Why?
|
| Retinal Ganglion Cells | 2 | 2018 | 806 | 0.110 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 58681 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 1793 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 2013 | 1342 | 0.110 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2018 | 0.110 |
Why?
|
| Aging | 3 | 2008 | 8651 | 0.110 |
Why?
|
| Pterygium | 1 | 2013 | 26 | 0.110 |
Why?
|
| Receptors, Histamine H1 | 1 | 2013 | 19 | 0.110 |
Why?
|
| Chromones | 1 | 2013 | 148 | 0.110 |
Why?
|
| Adult | 25 | 2021 | 219916 | 0.110 |
Why?
|
| Autoantibodies | 2 | 2020 | 2118 | 0.110 |
Why?
|
| Tyrphostins | 2 | 2003 | 63 | 0.110 |
Why?
|
| Cell Differentiation | 5 | 2017 | 11471 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2018 | 1514 | 0.110 |
Why?
|
| Occupational Diseases | 1 | 2021 | 1486 | 0.110 |
Why?
|
| Endosomes | 1 | 1996 | 519 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 563 | 0.110 |
Why?
|
| Methylhistamines | 1 | 2012 | 4 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2018 | 3480 | 0.100 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 2003 | 110 | 0.100 |
Why?
|
| Stem Cell Transplantation | 2 | 2018 | 1599 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1557 | 0.100 |
Why?
|
| Cimetidine | 1 | 2012 | 76 | 0.100 |
Why?
|
| Sex Factors | 2 | 2024 | 10505 | 0.100 |
Why?
|
| Pituitary Gland, Posterior | 3 | 1981 | 42 | 0.100 |
Why?
|
| Amino Acids | 1 | 2018 | 1713 | 0.100 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2011 | 13 | 0.100 |
Why?
|
| Glaucoma | 2 | 2019 | 1182 | 0.100 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1992 | 146 | 0.100 |
Why?
|
| Indoles | 2 | 2012 | 1828 | 0.100 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2018 | 250 | 0.100 |
Why?
|
| Thiazoles | 2 | 2012 | 1511 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 3 | 1982 | 1066 | 0.100 |
Why?
|
| Receptors, Purinergic P2X1 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Suramin | 1 | 2011 | 34 | 0.100 |
Why?
|
| 1-Butanol | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6209 | 0.100 |
Why?
|
| Phenotype | 5 | 2017 | 16534 | 0.100 |
Why?
|
| Administration, Topical | 5 | 1995 | 697 | 0.100 |
Why?
|
| Corneal Neovascularization | 2 | 2004 | 185 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 1130 | 0.100 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2011 | 37 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 481 | 0.090 |
Why?
|
| Time Factors | 8 | 2011 | 39873 | 0.090 |
Why?
|
| Young Adult | 11 | 2020 | 58808 | 0.090 |
Why?
|
| Vimentin | 1 | 2011 | 255 | 0.090 |
Why?
|
| Allergens | 1 | 2018 | 1402 | 0.090 |
Why?
|
| Actinin | 1 | 2011 | 163 | 0.090 |
Why?
|
| Regeneration | 2 | 2017 | 1505 | 0.090 |
Why?
|
| Leukotriene C4 | 1 | 2011 | 79 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2021 | 1743 | 0.090 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 1981 | 48 | 0.090 |
Why?
|
| Keratoconjunctivitis Sicca | 1 | 1990 | 26 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2015 | 1414 | 0.090 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 2 | 1981 | 56 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2497 | 0.090 |
Why?
|
| Receptors, Leukotriene | 1 | 2011 | 95 | 0.090 |
Why?
|
| Thiolester Hydrolases | 2 | 2001 | 85 | 0.090 |
Why?
|
| Biopsy | 2 | 2012 | 6768 | 0.090 |
Why?
|
| Eye | 1 | 2014 | 710 | 0.090 |
Why?
|
| Transduction, Genetic | 2 | 2004 | 896 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2007 | 213 | 0.090 |
Why?
|
| Morpholines | 1 | 2013 | 580 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2005 | 370 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2010 | 490 | 0.090 |
Why?
|
| Acetylcholine | 7 | 2005 | 628 | 0.090 |
Why?
|
| Blinking | 2 | 2022 | 133 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2010 | 202 | 0.090 |
Why?
|
| Nucleotides, Cyclic | 1 | 1990 | 84 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2013 | 1991 | 0.080 |
Why?
|
| Diterpenes | 2 | 2007 | 169 | 0.080 |
Why?
|
| Egtazic Acid | 2 | 1998 | 169 | 0.080 |
Why?
|
| Military Personnel | 2 | 2015 | 1244 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 10171 | 0.080 |
Why?
|
| Atropine | 4 | 1995 | 244 | 0.080 |
Why?
|
| Monocytes | 1 | 2018 | 2570 | 0.080 |
Why?
|
| Adenoviridae | 2 | 2004 | 1084 | 0.080 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2001 | 74 | 0.080 |
Why?
|
| Phorbol Esters | 1 | 1988 | 108 | 0.080 |
Why?
|
| Butadienes | 1 | 2008 | 107 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2010 | 351 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 544 | 0.080 |
Why?
|
| Protein Kinase C-delta | 2 | 2000 | 114 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 877 | 0.080 |
Why?
|
| Esophagogastric Junction | 2 | 2003 | 341 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 730 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 113 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2003 | 2433 | 0.080 |
Why?
|
| Rabbits | 9 | 2005 | 4771 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 2858 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 1688 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2005 | 4406 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1229 | 0.080 |
Why?
|
| Dacryocystitis | 2 | 1998 | 68 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1651 | 0.080 |
Why?
|
| Efferent Pathways | 1 | 2008 | 165 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 2009 | 325 | 0.080 |
Why?
|
| Ligands | 2 | 2007 | 3258 | 0.080 |
Why?
|
| Tropicamide | 1 | 2007 | 22 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2001 | 454 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 2057 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2008 | 198 | 0.070 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2007 | 135 | 0.070 |
Why?
|
| Genomics | 1 | 2023 | 5789 | 0.070 |
Why?
|
| Enzyme Activators | 1 | 2007 | 57 | 0.070 |
Why?
|
| Metabolomics | 1 | 2017 | 1629 | 0.070 |
Why?
|
| Mydriatics | 1 | 2007 | 67 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4342 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2018 | 3090 | 0.070 |
Why?
|
| Carbazoles | 1 | 2008 | 220 | 0.070 |
Why?
|
| Neuregulin-1 | 1 | 2007 | 135 | 0.070 |
Why?
|
| Adolescent | 10 | 2021 | 87888 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 687 | 0.070 |
Why?
|
| ROC Curve | 3 | 2020 | 3563 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2872 | 0.070 |
Why?
|
| Tetrazolium Salts | 1 | 2006 | 92 | 0.070 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2007 | 137 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2007 | 198 | 0.070 |
Why?
|
| Quinazolines | 2 | 2003 | 1360 | 0.070 |
Why?
|
| Pupil | 1 | 2007 | 142 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 215 | 0.070 |
Why?
|
| Anterior Eye Segment | 1 | 2007 | 141 | 0.070 |
Why?
|
| Tetrazoles | 1 | 2011 | 899 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 1245 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 341 | 0.060 |
Why?
|
| Histocytochemistry | 1 | 2006 | 700 | 0.060 |
Why?
|
| Receptor, erbB-2 | 2 | 2007 | 2553 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 174 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2006 | 522 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2006 | 1141 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2007 | 535 | 0.060 |
Why?
|
| Intracellular Membranes | 2 | 2002 | 389 | 0.060 |
Why?
|
| Protein Transport | 2 | 2008 | 1963 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3796 | 0.060 |
Why?
|
| Thapsigargin | 2 | 2003 | 102 | 0.060 |
Why?
|
| Verapamil | 2 | 1985 | 242 | 0.060 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2023 | 24 | 0.060 |
Why?
|
| Cloprostenol | 1 | 2023 | 21 | 0.060 |
Why?
|
| Axons | 2 | 2018 | 1674 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 54136 | 0.060 |
Why?
|
| Phylogeny | 1 | 2011 | 2774 | 0.060 |
Why?
|
| Ophthalmic Nerve | 2 | 2001 | 42 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2006 | 560 | 0.060 |
Why?
|
| Nitriles | 1 | 2008 | 957 | 0.060 |
Why?
|
| Nigericin | 1 | 2023 | 10 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2004 | 557 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 940 | 0.050 |
Why?
|
| Lymphocytes | 3 | 2005 | 2610 | 0.050 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2002 | 75 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 1997 | 251 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 1998 | 950 | 0.050 |
Why?
|
| Sulfonamides | 2 | 2010 | 1973 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 130 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5864 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 135 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14354 | 0.050 |
Why?
|
| Kinetics | 5 | 1992 | 6371 | 0.050 |
Why?
|
| Subcellular Fractions | 3 | 1999 | 532 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 906 | 0.050 |
Why?
|
| Fluorescein | 1 | 2022 | 174 | 0.050 |
Why?
|
| RNA | 2 | 2003 | 2716 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 703 | 0.050 |
Why?
|
| Pain | 1 | 2017 | 5065 | 0.050 |
Why?
|
| Glucose | 1 | 2014 | 4336 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1878 | 0.050 |
Why?
|
| Steam | 1 | 2021 | 32 | 0.050 |
Why?
|
| Computer Terminals | 1 | 2021 | 41 | 0.050 |
Why?
|
| Refractive Surgical Procedures | 1 | 2001 | 22 | 0.050 |
Why?
|
| Exocytosis | 2 | 2005 | 319 | 0.050 |
Why?
|
| Harderian Gland | 1 | 1980 | 3 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3132 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 460 | 0.050 |
Why?
|
| Ionophores | 1 | 2000 | 107 | 0.050 |
Why?
|
| Alcian Blue | 1 | 2000 | 13 | 0.050 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 2000 | 16 | 0.050 |
Why?
|
| Biological Transport | 2 | 2002 | 2084 | 0.050 |
Why?
|
| Marine Toxins | 1 | 2000 | 24 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2023 | 696 | 0.040 |
Why?
|
| Gels | 1 | 2021 | 419 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 672 | 0.040 |
Why?
|
| Models, Animal | 1 | 2007 | 2112 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2016 | 12096 | 0.040 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2021 | 266 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 7583 | 0.040 |
Why?
|
| Lymphokines | 1 | 2003 | 926 | 0.040 |
Why?
|
| S Phase | 1 | 2000 | 422 | 0.040 |
Why?
|
| G1 Phase | 1 | 2000 | 403 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2860 | 0.040 |
Why?
|
| Ethylene Glycols | 1 | 1980 | 190 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 4429 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2021 | 472 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 383 | 0.040 |
Why?
|
| Staurosporine | 1 | 2000 | 242 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 835 | 0.040 |
Why?
|
| DNA Primers | 1 | 2003 | 2816 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14641 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 25953 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 3 | 2011 | 1705 | 0.040 |
Why?
|
| Child | 7 | 2020 | 79813 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 482 | 0.040 |
Why?
|
| Oxazoles | 1 | 2000 | 199 | 0.040 |
Why?
|
| Sodium Chloride | 2 | 1996 | 588 | 0.040 |
Why?
|
| Neurons | 1 | 1998 | 9418 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 235 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2016 | 4114 | 0.040 |
Why?
|
| Endothelium, Corneal | 1 | 2000 | 214 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1404 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 330 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7843 | 0.040 |
Why?
|
| Zirconium | 1 | 2018 | 107 | 0.040 |
Why?
|
| Thermoreceptors | 1 | 2017 | 27 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2016 | 2905 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2022 | 1732 | 0.040 |
Why?
|
| Potassium | 1 | 1981 | 1310 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1613 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 1981 | 832 | 0.040 |
Why?
|
| Myristates | 1 | 1997 | 12 | 0.040 |
Why?
|
| Incidence | 1 | 2015 | 21273 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3783 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 1999 | 1792 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22031 | 0.040 |
Why?
|
| Norway | 1 | 2018 | 496 | 0.040 |
Why?
|
| Immunity | 1 | 2023 | 998 | 0.030 |
Why?
|
| Bacteria | 1 | 2007 | 2199 | 0.030 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 74 | 0.030 |
Why?
|
| Cholinergic Agents | 1 | 1997 | 96 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2000 | 708 | 0.030 |
Why?
|
| Hydroxylamine | 1 | 1996 | 16 | 0.030 |
Why?
|
| Digitonin | 1 | 1996 | 26 | 0.030 |
Why?
|
| Neurites | 1 | 2018 | 390 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
| Octoxynol | 1 | 1996 | 77 | 0.030 |
Why?
|
| Sodium | 1 | 1981 | 1588 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2016 | 351 | 0.030 |
Why?
|
| Hemagglutinins | 1 | 1996 | 113 | 0.030 |
Why?
|
| Hydroxylamines | 1 | 1996 | 40 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1997 | 348 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2022 | 1434 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2019 | 911 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2211 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2001 | 1110 | 0.030 |
Why?
|
| Chlorides | 1 | 2018 | 663 | 0.030 |
Why?
|
| Sensation | 1 | 2017 | 331 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 1159 | 0.030 |
Why?
|
| Fluorometry | 1 | 2015 | 100 | 0.030 |
Why?
|
| Keratin-19 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Phosphatidic Acids | 1 | 1995 | 49 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2015 | 245 | 0.030 |
Why?
|
| Diacylglycerol Kinase | 1 | 1995 | 48 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 2204 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 73806 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2015 | 234 | 0.030 |
Why?
|
| Stearic Acids | 1 | 1995 | 56 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 861 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 1995 | 129 | 0.030 |
Why?
|
| Piperidines | 1 | 2003 | 1639 | 0.030 |
Why?
|
| Methoxamine | 1 | 1994 | 45 | 0.030 |
Why?
|
| Fluorophotometry | 1 | 2014 | 40 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15773 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 1894 | 0.030 |
Why?
|
| Timolol | 1 | 1994 | 51 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 1997 | 5098 | 0.030 |
Why?
|
| Retinal Neurons | 1 | 2014 | 66 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2015 | 200 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 371 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 2014 | 100 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5629 | 0.030 |
Why?
|
| Cytosol | 1 | 2017 | 886 | 0.030 |
Why?
|
| Phthalic Acids | 1 | 2018 | 477 | 0.030 |
Why?
|
| Nociceptors | 1 | 2017 | 457 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2416 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1995 | 2557 | 0.030 |
Why?
|
| Ouabain | 2 | 1985 | 247 | 0.030 |
Why?
|
| Clonidine | 1 | 1994 | 169 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2003 | 4087 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 986 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2014 | 377 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 1288 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1754 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2205 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 258 | 0.030 |
Why?
|
| Fluorescence | 1 | 2015 | 749 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 728 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1994 | 664 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 435 | 0.030 |
Why?
|
| Neurobiology | 1 | 2013 | 137 | 0.030 |
Why?
|
| Injections | 1 | 1995 | 830 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 726 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 850 | 0.030 |
Why?
|
| Haloperidol | 1 | 1994 | 388 | 0.030 |
Why?
|
| Lidocaine | 1 | 1995 | 537 | 0.030 |
Why?
|
| Propoxycaine | 2 | 1990 | 6 | 0.030 |
Why?
|
| HEPES | 1 | 2011 | 10 | 0.030 |
Why?
|
| Mast Cells | 2 | 2013 | 1390 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 388 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1994 | 405 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 940 | 0.020 |
Why?
|
| Complex Mixtures | 1 | 2011 | 29 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 148 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2003 | 3040 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2011 | 48 | 0.020 |
Why?
|
| Secretory Rate | 2 | 1981 | 81 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2011 | 174 | 0.020 |
Why?
|
| Epinephrine | 1 | 1995 | 790 | 0.020 |
Why?
|
| Microvilli | 1 | 2011 | 233 | 0.020 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2014 | 301 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1994 | 897 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15785 | 0.020 |
Why?
|
| Esophagus | 1 | 1997 | 1023 | 0.020 |
Why?
|
| Gentamicins | 1 | 2011 | 251 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 869 | 0.020 |
Why?
|
| Eledoisin | 1 | 1990 | 2 | 0.020 |
Why?
|
| Pilocarpine | 1 | 1990 | 64 | 0.020 |
Why?
|
| Rose Bengal | 1 | 1991 | 115 | 0.020 |
Why?
|
| Isomerism | 1 | 1990 | 197 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 1186 | 0.020 |
Why?
|
| United States | 2 | 2015 | 72140 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1994 | 656 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6036 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 2004 | 735 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1990 | 140 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 573 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8530 | 0.020 |
Why?
|
| Fibronectins | 1 | 2013 | 722 | 0.020 |
Why?
|
| Inositol | 1 | 1990 | 215 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 80170 | 0.020 |
Why?
|
| Cats | 2 | 2003 | 975 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4258 | 0.020 |
Why?
|
| Vipoma | 1 | 1988 | 7 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2697 | 0.020 |
Why?
|
| Adenoma, Islet Cell | 1 | 1988 | 72 | 0.020 |
Why?
|
| Cell Line | 2 | 2018 | 15594 | 0.020 |
Why?
|
| Cell Communication | 1 | 2016 | 1651 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9405 | 0.020 |
Why?
|
| Quality of Life | 2 | 2021 | 13286 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 1995 | 1000 | 0.020 |
Why?
|
| Ethanol | 1 | 1995 | 1325 | 0.020 |
Why?
|
| Peptide PHI | 1 | 1988 | 4 | 0.020 |
Why?
|
| Sincalide | 1 | 1988 | 15 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1398 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2013 | 1047 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 1989 | 282 | 0.020 |
Why?
|
| Metabolome | 1 | 2015 | 982 | 0.020 |
Why?
|
| Focus Groups | 1 | 2013 | 1382 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2907 | 0.020 |
Why?
|
| Ions | 1 | 1988 | 256 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2007 | 111 | 0.020 |
Why?
|
| Macrophages | 1 | 2022 | 5737 | 0.020 |
Why?
|
| Retina | 1 | 2018 | 2637 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3774 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2017 | 6353 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2007 | 260 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1988 | 489 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1539 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 1337 | 0.020 |
Why?
|
| Reflex | 1 | 1988 | 376 | 0.020 |
Why?
|
| Cattle | 3 | 1981 | 3846 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2038 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 17617 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3533 | 0.020 |
Why?
|
| Gallic Acid | 1 | 1985 | 24 | 0.020 |
Why?
|
| Models, Biological | 2 | 1998 | 9461 | 0.020 |
Why?
|
| Lipofuscin | 1 | 2005 | 40 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1988 | 534 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14481 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2005 | 139 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 41252 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 20052 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1988 | 1745 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 2003 | 27 | 0.010 |
Why?
|
| Phenanthridines | 1 | 2003 | 51 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2003 | 56 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7403 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2007 | 1006 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 281 | 0.010 |
Why?
|
| Oxygen | 1 | 2015 | 4192 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 2003 | 138 | 0.010 |
Why?
|
| Interleukin-17 | 1 | 2009 | 908 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2005 | 411 | 0.010 |
Why?
|
| Diglycerides | 1 | 2003 | 176 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3609 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 1456 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 13447 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1982 | 37 | 0.010 |
Why?
|
| Alkaloids | 1 | 2003 | 191 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 29915 | 0.010 |
Why?
|
| Membrane Potentials | 2 | 1988 | 1094 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 574 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 575 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2723 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8611 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2005 | 9518 | 0.010 |
Why?
|
| Nictitating Membrane | 1 | 1980 | 9 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 747 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 1984 | 539 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1543 | 0.010 |
Why?
|
| Furosemide | 1 | 1981 | 170 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2004 | 663 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1433 | 0.010 |
Why?
|
| Autoradiography | 1 | 1981 | 730 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 1233 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 311 | 0.010 |
Why?
|
| Cyclin E | 1 | 2000 | 156 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 1647 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 1125 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1593 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6233 | 0.010 |
Why?
|
| Palmitates | 1 | 1999 | 70 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 687 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1694 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1999 | 149 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 363 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 640 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1980 | 2185 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6068 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2003 | 855 | 0.010 |
Why?
|
| Orbit | 1 | 1980 | 446 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4353 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 1757 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4711 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5199 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5779 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6520 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 64379 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42058 | 0.010 |
Why?
|
| DNA Replication | 1 | 2000 | 1410 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12262 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12951 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1988 | 5349 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1988 | 436 | 0.000 |
Why?
|
| Neurophysins | 1 | 1980 | 14 | 0.000 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1980 | 122 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1980 | 299 | 0.000 |
Why?
|
| Centrifugation | 1 | 1980 | 122 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1980 | 573 | 0.000 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1980 | 477 | 0.000 |
Why?
|